Effects of waterfall aerosol on paediatric allergic asthma

Effects of waterfall aerosol on paediatric allergic asthma: a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN04002573

Enrollment

Registered

2011-12-23

Start date

2007-01-01

Completion date

Unknown

Last updated

2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma bronchiole Respiratory Asthma

Interventions

Intervention: Climate therapy (Asthma Camp in the Alps) at the site of a waterfall 1 hour in the day Control: Climate therapy (Asthma Camp in the Alps) not at the site of a waterfall 1

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Male/female children aged 8-15 years with mild to moderate persistent asthma according to Global Initiative on Asthma (GINA) guidelines 2. Minimum medication to achieve adequate asthma control with inhaled corticosteroids and beta-sympathomimetics on demand

Exclusion criteria

Exclusion criteria: 1. Systemic corticosteroids 2. Severe uncontrolled asthma

Design outcomes

Primary

Measure	Time frame
1. Symptome score - Asthma control test (ACT) at day 1,11,19,50,80,140 2. Lung function (spirometry at day 0,3,7,9,11,13,15,17,19,20,80) 3. Exhaled nitrix oxide (NO) (FeNO) at day 0,10,14,18,20,80	—

Secondary

Measure	Time frame
Immunological parameters of allergic inflammation (blood collection at day 1, 20)	—

Countries

Austria, Bosnia and Herzegovina, Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026